Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania.

Moreno RA, Hanna MM, Tavares SM, Wang YP.

Braz J Med Biol Res. 2007 Mar;40(3):357-66.

2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
4.

Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.

Berk M, Ng F, Wang WV, Tohen M, Lubman DI, Vieta E, Dodd S.

J Affect Disord. 2008 Sep;110(1-2):126-34. doi: 10.1016/j.jad.2008.01.018. Epub 2008 Feb 15.

PMID:
18280579
5.

Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.

Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, Tohen M.

J Clin Psychiatry. 2006 Nov;67(11):1747-53.

PMID:
17196055
6.

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.

J Clin Psychiatry. 2001 Apr;62(4):273-81.

PMID:
11379842
7.
8.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
9.

Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

J Affect Disord. 2012 Feb;136(3):476-84. doi: 10.1016/j.jad.2011.10.045. Epub 2011 Nov 30.

PMID:
22134043
10.

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.

Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A.

Arch Gen Psychiatry. 2003 Dec;60(12):1218-26.

PMID:
14662554
11.

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2000 Sep;57(9):841-9. Erratum in: Arch Gen Psychiatry 2002 Jan;59(1):91.

PMID:
10986547
12.

Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.

Wang M, Tong JH, Huang DS, Zhu G, Liang GM, Du H.

Psychopharmacology (Berl). 2014 Jul;231(14):2811-8. doi: 10.1007/s00213-014-3453-1. Epub 2014 Jan 31.

PMID:
24481570
13.

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial.

Berk M, Ichim L, Brook S.

Int Clin Psychopharmacol. 1999 Nov;14(6):339-43.

PMID:
10565800
14.

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.

Lazowski LK, Townsend B, Hawken ER, Jokic R, du Toit R, Milev R.

BMC Psychiatry. 2014 Jul 17;14:202. doi: 10.1186/1471-244X-14-202.

15.
16.
17.

Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.

Szegedi A, Zhao J, McIntyre RS.

J Affect Disord. 2013 Sep 25;150(3):745-52. doi: 10.1016/j.jad.2013.01.024. Epub 2013 Mar 6.

PMID:
23473546
18.

Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.

Treuer T, Oruc L, Loza N, El Saidi MA, Kovacs Z, Akkaya C, G├╝lseren S, Saylan M, Colman SA, Harrison GA.

Psychiatr Danub. 2007 Dec;19(4):282-95.

PMID:
18000479
19.
20.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

Supplemental Content

Support Center